Abstract
This study assesses the behavioural significance of the (-)sulpiride binding sites in the rat nucleus accumbens that bind antidepressants with high affinity and neuroleptics with low affinity. The effects were measured by intra-accumbens injections of typical and atypical antidepressants or neuroleptics, either given alone or in combination with ergometrine (1 μg/0.5 μl per side) on rat locomotor activity in a familiar environment. In addition, the after-effects of the combined ergometrine-drug treatment upon locomotor activity were analyzed. The antidepressants shared a common profile of effects. Thus, none of the antidepressants significantly altered locomotor activity in naive rats. Moreover, each antidepressant produced after-effects which were similar to those elicited in the acute ergometrine experiments. However, some antidepressants (amitriptyline and zimelidine) potentiated the ergometrine response, while other antidepressants (desipramine, mianserin and clorgyline) attenuated this response. (-)Sulpiride (0.5 μg) decreased the ergometrine response when given together with ergometrine or 48 h earlier. Haloperidol had to be given in a dose that was 20 times higher than that of (-)sulpiride in order to be effective. Clozapine (1–10 μg) failed to alter the ergometrine response when given together with ergometrine. Only (-)sulpiride produced a dose-dependent attenuation of locomotor activity in naive rats. The present data are discussed in terms of the hypothesis that drugs with antidepressive effects mediate their behavioural effects via mesolimbic (-)sulpiride binding sites.
Similar content being viewed by others
References
Angst J, Koukkou M, Bleuler-Herzog M, Martens H (1974) Ergebnisse eines offenen und einen Doppelblindversuches von Nomifensin im Vergleich zu Imipramin. Arch Psychiat Nervenkr 219:265–276
Arnt J (1983) Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Eur J Pharmacol 90:47–55
Benkert O, Holsboer F (1984) Effect of sulpiride in endogeneous depression. Acta Psychiatry Scand [Suppl 311] 69:43–48
Chiodo LA, Antelman SM (1980) Repeated tricyclics induce a progressive dopamine autorecptor subsensitivity independent of daily drug treatment. Nature (London) 287:451–454
Cools AR (1986) Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens. Psychopharmacology 88:451–459
Cools AR (1987) Mesolimbic noradrenaline and its role in behaviour: specificity, stability and dose-dependency of individual-specific responses to mesolimbic injections of α-noradrenergic agonists. Beh Brain Res (in press)
Cools AR, Oosterloo SK (1983) (3,4-Dihydroxyphenylimino)-2-Imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity. J Neural Transm [Suppl] 18:181–188
Cools AR, Struyker Boudier HAJ, van Rossum JM (1976) Dopamine receptors: selective agonists and antagonists of functionally distinct types within the feline brain. Eur J Pharmacol 37:283–293
Costall B, Fortune DH, Hui SG, Naylor RJ (1980) Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens. Eur J Pharmacol 63:347–358
Csernansky JG, Csernansky CA, Hollister LE (1985) 3(H)-Sulpiride labels mesolimbic non-dopaminergic sites that bind antidepressant drugs. Experientia 41:1419–1421
Eichenberger E (1984) Pharmacology of fluperlapine compared with clozapine. Arzneimittel-Forsch Drug Res 34(1):110–113
Ferguson GA (1981) Statistical analysis in psychology and education. McGraw-Hill, Singapore, pp 251–293
Honda F, Satoh Y, Shimomura K, Satoh H, Noguchi H, Uschida S-I, Kato R (1977) Dopamine receptor blocking activity of sulpiride in the central nervous system. Jpn J Pharmacol 27:397–411
Jenner P, Marsden CD (1981) Substituted benzamide drugs as selective neuroleptic agents. Neuropharmacology 20:1285–1293
König FRJ, Klippel RA (1963) The rat brain. Williams and Wilkins, Baltimore
Lorens SA, Sorensen JP, Harvey JA (1970) Lesions in the nuclei accumbens septi of the rat: behavioral and neurochemical effects. J Comp Physiol Psychol 73:284–290
Mogenson GJ, Nielsen M (1984) Neuropharmacological evidence to suggest that the nucleus accumbens and subpallidal region contribute to exploratory locomotion. Behav Neural Biol 42:52–60
Nieuwenhuys R (1985) Chemoarchitecture of the brain. Springer, Berlin Heidelberg New York Tokyo, pp 178
Oosterloo SK, Cools AR (1985) Typical and atypical antidepressant drug effects on locomotor activity, after intra-accumens injections in the rat. Eur J Pharmacol 118:45–51
Pijnenburg AJ, Woodruff GN, van Rossum JM (1973) Ergometrine induced locomotor activity following intra-cerebral injection into the nucleus accumbens. Brain Res 59:289–302
Pijnenburg AJJ, Honig WMM, Struyker Boudier HAJ, Cools AR, van der Heyden JAM, van Rossum JM (1976) Further investigations on the effects of ergometrine and other ergot derivatives following injection into the nucleus accumbens of rats. Arch Int Pharmacodyn 222:103–115
Randrup A, Munkvad I, Fog R, Gerlach J, Molander L, Kjellberg B, Scheel-Krüger J (1975) Mania, depression, and brain dopamine. In: Essman WB, Valzelli L (eds) Current developments in psychopharmacology, vol. 2. Spectrum, New York, pp 207–248
Van Schleyen JD, van Praag HM, Korf J (1977) Controlled study comparing nomifensine and clomipramine in unipolar depression, using the probenecid technique. Br J Clin Pharmacol 4:1793–1845
Shopsin B, Gershon S (1971) Plasma cortisol response to dexamphetamine suppression in depressant and control patients. Arch Gen Psychiatry 24:320–326
Spyraki C, Fibiger HC (1981) Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur J Pharmacol 74:195–206
Standish-Barry H, Bouras N, Bridges P, Watson J (1983) A randomized double blind group comparative study of sulpiride and amitriptyline in affective disorder. Psychopharmacology 81:258–260
Struyker Boudier HAJ, Cools AR (1984) (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI): a stimulant of α-adrenoceptors and dopamine receptors. J Pharm Pharmacol 36:859–860
Willner P (1983a) Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res Rev 6:211–224
Willner P (1983b) Dopamine and depression: a review of recent evidence. II. Theoretical approaches. Brain Res Rev 6:225–236
Willner P (1983c) Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments. Brain Res Rev 6:237–246
Woggon B, Heinrich K, Küfferle B, Müller-Oerlinghausen B, Pöldinger W, Rüther E, Schied HW (1984) Results of a multicenter AMDP study with fluperlapine in schizophrenic patients. Arzneimittelforschung/Drug Res 34:(1)122–124
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cools, A.R. The nucleus accumbens and antidepressants: modulation of ergometrine-induced hyperactivity by typical and atypical antidepressants and neuroleptics in rats. Psychopharmacology 92, 350–357 (1987). https://doi.org/10.1007/BF00210843
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00210843